Sei Investments Co. Increases Holdings in NCR Atleos Corporation $NATL

Sei Investments Co. increased its position in NCR Atleos Corporation (NYSE:NATL) by 25.9% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 109,928 shares of the company’s stock after buying an additional 22,627 shares during the quarter. Sei Investments Co.’s holdings in NCR Atleos were worth $4,791,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. CIBC Private Wealth Group LLC grew its position in NCR Atleos by 66.7% during the fourth quarter. CIBC Private Wealth Group LLC now owns 690 shares of the company’s stock valued at $26,000 after acquiring an additional 276 shares during the last quarter. Sound Income Strategies LLC lifted its holdings in shares of NCR Atleos by 245.7% in the 1st quarter. Sound Income Strategies LLC now owns 643 shares of the company’s stock worth $28,000 after acquiring an additional 457 shares during the last quarter. Eurizon Capital SGR S.p.A. bought a new stake in shares of NCR Atleos in the 4th quarter worth approximately $31,000. Global Retirement Partners LLC boosted its stake in shares of NCR Atleos by 134.5% in the 4th quarter. Global Retirement Partners LLC now owns 1,210 shares of the company’s stock valued at $46,000 after purchasing an additional 694 shares in the last quarter. Finally, Kestra Advisory Services LLC purchased a new stake in shares of NCR Atleos in the 4th quarter valued at $51,000. Hedge funds and other institutional investors own 88.66% of the company’s stock.

Analysts Set New Price Targets

NATL has been the topic of several recent research reports. Zacks Research lowered shares of NCR Atleos from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 27th. DA Davidson restated a “neutral” rating and set a $50.00 price target on shares of NCR Atleos in a research report on Monday, May 11th. Finally, Weiss Ratings lowered shares of NCR Atleos from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, May 8th. Six investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, NCR Atleos presently has a consensus rating of “Hold” and an average price target of $50.27.

NCR Atleos Stock Performance

NCR Atleos stock opened at $46.85 on Thursday. The company has a current ratio of 0.98, a quick ratio of 0.78 and a debt-to-equity ratio of 6.83. The firm has a market cap of $3.46 billion, a P/E ratio of 20.19 and a beta of 0.57. NCR Atleos Corporation has a 1-year low of $31.28 and a 1-year high of $48.50. The firm has a 50-day moving average of $45.17 and a 200-day moving average of $43.72.

NCR Atleos (NYSE:NATL) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.24). NCR Atleos had a net margin of 3.98% and a return on equity of 78.64%. The business had revenue of $1.04 billion for the quarter. During the same quarter in the previous year, the company posted $0.64 EPS. NCR Atleos’s revenue for the quarter was up 6.5% compared to the same quarter last year. Sell-side analysts expect that NCR Atleos Corporation will post 4.52 EPS for the current year.

About NCR Atleos

NCR Atleos Corporation operates as a financial technology company in the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Self-Service Banking, Network, and Telecommunications & Technology (T&T). The Self-Service Banking segment offers solutions, including a line of automated teller machine (ATM) and interactive teller machine (ITM) hardware and software, as well as related installation, maintenance, and managed and professional services; and solutions to manage and run the ATM channel end-to-end for financial institutions comprising back office, cash management, software management and ATM deployment, and others.